Skin Cancer
Merkel Cell Carcinoma
Male, 74 years
Patient Internal ID: 499414644
ICD-10 code
C44.7 Malignant Neoplasms of Skin of Lower Limb and Hip
Diagnosis (Incl. Metastases/Stage) and Year
January 2020
Merkel Cell Carcinoma cTxN2M1, Metastasis to Right Inguinal Lymph Node, Skin of Right Leg.
Previous Treatment
Radiation Therapy, Chemotherapy (Cisplatin/ Etoposide).
Prognosis and Survival Expectation
Merkel Cell Carcinoma (MCC) is a rare but aggressive Skin Cancer. The prognosis remains poor, the development of distant metastases portends a poor prognosis, with a mean life expectancy of 5 months. The 5-year relative survival rate for Advanced Merkel Cell Carcinoma is 24%.
Treatment Provided
CIK (12 doses) o ver a period of 5 months.
Patient Survival/Condition and Year
Date of Review: 28/12/2023
The patient has survived for 11 months since the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Chemotherapy and Radiation Therapy, has extended patient survival by an estimate of around 6 months.
